  | LEJEUNE, M., Menard, B., Servais, S., ANDRIANNE, C., Capelle, L., De Maistre, S., Fabaron, C., Cornier, M. F., Goutagny, M.-P., Pereira, M., Tardy, C., Turquet, E., Benakli, M., BAUDOUX, E., Evard, S., Faucher, C., Herrero, G., RESILIAM, Magro, L., & Geurten, C. (2025). Don de cellules souches hématopoïétiques à partir d’un donneur mineur : cadre réglementaire, information, évaluation de l’aptitude au don et parcours (SFGM-TC). Bulletin du Cancer, 112, 78-S86. doi:10.1016/j.bulcan.2024.04.002  Peer Reviewed verified by ORBi |
  | El Moussaoui, M., Bontems, S., Meex, C., Hayette, M.-P., LEJEUNE, M., Hong, S. L., Dellicour, S., Moutschen, M., CAMBISANO, N., Renotte, N., Bours, V., Darcis, G., Artesi, M.* , & Durkin, K.*. (04 March 2024). Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection. Virus Evolution, 10 (1), 073. doi:10.1093/ve/veae073 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598 Peer Reviewed verified by ORBi |
 | Erpicum, P., Grosch, S., Bonvoisin, C., Bouquegneau, A., Weekers, L., Radermacher, L., Jouret, F., LEJEUNE, M., Hougrand, O., & Bovy, C. (2022). The Case | An unusual cause of renal vascular thrombi after kidney transplantation. Kidney International, 101 (2), 427-428. doi:10.1016/j.kint.2021.08.008 Peer Reviewed verified by ORBi |
 | Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534. Peer reviewed |
 | Devos T., Verhoef G., Steel E., Mazure D., Lewalle P., Bron D., Berneman Z., Benghiat FS., MIneur P., Theunissen K., Zachée P., Doyen C., Put N., LEJEUNE, M., Van Eygen K., Havelange V., Reusens M., Pluymers W., & Peeters K. (2019). Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium. Acta Haematologica, 142 (197-207). doi:10.1159/000499329 Peer Reviewed verified by ORBi |
SID, S., Baron, F., WILLEMS, E., Caers, J., Bonnet, C., DE PRIJCK, B., LEJEUNE, M., HAFRAOUI, K., Servais, S., JASPERS, A., & Beguin, Y. (November 2016). Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients [Paper presentation]. 16ème Congrès commun de la SFGM-TC & 8ème de la SFBCT, Liège, Belgium. |
 | JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100 Peer Reviewed verified by ORBi |
 | Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556. Peer Reviewed verified by ORBi |
 | MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068 Peer Reviewed verified by ORBi |
 | Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90. Peer Reviewed verified by ORBi |
 | Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011 Peer Reviewed verified by ORBi |
 | Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium. |
 | Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63. Peer reviewed |